Reported congenital malformations after exposure to non‐tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance

AIMS: To evaluate the number and nature of reported congenital malformations (CMs) after intrauterine exposure to non‐tumour necrosis factor inhibitor biologics (non‐TNFi biologics) compared to certolizumab pegol (CZP). METHODS: A retrospective comparative study was conducted in the EudraVigilance (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghalandari, Nafise, Crijns, Hubertina J. M. J., Bergman, Jorieke E. H., Dolhain, Radboud J. E. M., van Puijenbroek, Eugène P., Hazes, Johanna M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804904/
https://www.ncbi.nlm.nih.gov/pubmed/35894810
http://dx.doi.org/10.1111/bcp.15471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804904/
https://www.ncbi.nlm.nih.gov/pubmed/35894810
http://dx.doi.org/10.1111/bcp.15471

Ejemplares similares